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Results: 47 male and 10 female patients were enrolled, 
median age was 61 years. All patients underwent 
radio(chemo)therapy for HNSCC, two patients who did not 
receive the prescribed dose, were excluded from further 
analysis. Mucositis G3 was observed in 21 patients and 
occurred between 17 and 50 days (mean 33d, ±SD 9d) after 
start of treatment. The contoured mucosal volumes ranged 
from 48cc to105cc (mean 68cc, ±SD 12cc). Univariate analysis 
revealed a significant difference of Dmax (p<0.0001) and V30 
(p=0.035) between patients with and without mucositis G3. 
ROC-curves indicated optimal cut off values of 68Gy for Dmax 
and V30≤73%. The positive predictive values were 56% and 
50%. The negative predictive values were 87% and 81%, 
respectively.  
Conclusions: A delineation consensus of the oral cavity 
mucosa based on anatomical borders on planning CTs was 
developed and successfully applied. The large negative 
predictive values of Dmax and V30 suggest that 
pretherapeutic identification of patients with a low risk of 
mucositis Grade 3 within a given treatment regimen is 
feasible. This information may be utilized for risk-
stratification of patients. The hypothesis generated in our 
study will now be validated in a prospective observational.  
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Purpose/Objective: Preoperative Radiotherapy or Chemo-
Radiotherapy for locally advanced rectal cancer (LARC) can 
cause acute and long-term small bowel (SB) side effects. 
Currently at the St Luke’s Radiation Oncology Network, 
preoperative LARC patients are treated using a 3D conformal 
radiotherapy (3DCRT). There is a dose volume relationship 
between small bowel irradiation and the development of 
acute grade diarrhoea1. Intensity Modulated Radiotherapy 
(IMRT) can improve SB sparing, which may thus reduce 
toxicity2. A planning study was undertaken to assess the 
reduction of SB dose, while maintaining PTV coverage using 
the options available within the VMAT optimizer in Eclipse, 
namely Avoidance Structures and Avoidance Sectors.  
Materials and Methods: Methods: A planning study was 
carried out on a total of 20 LARC patients with the aim of a 
significantly reducing the dose received by the SB. Patients 
were planned supine, with a full bladder and given IV 
contrast. No oral contrast was administered. Standard 
preoperative rectal volumes were drawn, based upon RTOG 
guideline, with the addition of bowel loops (small bowel and 
large bowel) for the purpose of assessment. For each of the 
20 patients, 5 plans were created:  
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1. A standard 3D plan;  
2. A standard 2 Arc RA plan;  
3. A RA plan with the use of an avoidance structure in the 
optimiser;  
4. A RA plan with the use of a 90o avoidance sector through 
the anterior portion of the patient;  
5. A RA plan with both the avoidance structure and avoidance 
sector used. Six Dose Volume Constraints (DVCs) (v15, v25, 
v35, v40, v50.4, v52.92) were selected to evaluate the 
effects of these plans in determining their effects in reducing 
dose to the SB. The DVCs were compared between the plans 
using a one-way repeated measures analysis of variance 
(ANOVA) 
 
Results: Comparison of the 5 plans showed that use of both 
an avoidance structure and sector with a RA plan improved 
the dose to the small bowel when compared with the other 
plans (p value <0.005). This technique similarly reduced the 
bladder volume. This was achieved whilst maintaining PTV 
coverage of 95-99.9% and an excellent conformity index 
(Table 1). 
 
 
 
Conclusions: The planning study has shown that with the use 
of both avoidance structures and an avoidance sector in 
tandem, we can ensure that dose to bowel is reduced for 
patients receiving a Rapid Arc VMAT plan compared to a 3D 
conformal plan in patients undergoing treatment for LARC. 
An Irish National Trial [ICORG 12-38, ‘TRI-LARC’] will 
randomise LARC patients to preoperative 3DCRT or 
IMRT/VMAT. For patients treated in ‘TRI-LARC’ with VMAT 
this planning paradigm will be followed. 
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Purpose/Objective: Adenoid cystic carcinoma (ACC) is rare, 
accounting for only 1-2% of all head and neck cancers. It is 
notable for its propensity for perineural invasion (PNI) in up 
to 96% of cases, which is associated with high rates of local 
failure and metastases along nerves up to the skull base. 
Retrospective series suggest that post-operative radiotherapy 
(RT) can reduce local recurrence rates from 30% to 10%. 
While there is good consensus in ACC of major salivary glands 
to include the course of the facial nerve or lingual nerve in 
RT treatment volumes, there is no recommendation regarding 
cranial nerve (CN) treatment in minor salivary gland tumors. 
In the era of highly conformal radiotherapy, an indepth 
understanding of the pathways of CNs from the soft tissue to 
the base of skull is necessary. The RTOG guideline on CN 
contouring is relatively limited, with description of nerves IX-
XII only and no information regarding neural pathways outside 
